FOXK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.841400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.797400E-01
Normal-vs-Stage2
3.419600E-01
Normal-vs-Stage3
2.178600E-01
Normal-vs-Stage4
8.547500E-02
Stage1-vs-Stage2
3.329000E-01
Stage1-vs-Stage3
4.009400E-01
Stage1-vs-Stage4
2.593600E-01
Stage2-vs-Stage3
5.303600E-01
Stage2-vs-Stage4
2.789200E-01
Stage3-vs-Stage4
6.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.343200E-01
Normal-vs-AfricanAmerican
7.318100E-02
Normal-vs-Asian
5.544400E-01
Caucasian-vs-AfricanAmerican
8.743900E-02
Caucasian-vs-Asian
8.964000E-01
AfricanAmerican-vs-Asian
4.337000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.870800E-01
Normal-vs-Female
6.990400E-01
Male-vs-Female
4.853600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.588400E-01
Normal-vs-Age(41-60Yrs)
7.062400E-01
Normal-vs-Age(61-80Yrs)
5.319400E-01
Normal-vs-Age(81-100Yrs)
5.131600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.498400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.726200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.242400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.308400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.224000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.451800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.677800E-01
Normal-vs-Daily Drinker
5.658400E-01
Normal-vs-Weekly Drinker
6.343600E-01
Normal-vs-Occasional Drinker
8.262800E-01
Normal-vs-Social Drinker
5.113600E-01
Non Drinker-vs-Daily Drinker
4.324800E-01
Non Drinker-vs-Weekly Drinker
3.999000E-01
Non Drinker-vs-Occasional Drinker
1.111010E-01
Non Drinker-vs-Social Drinker
3.681200E-01
Daily Drinker-vs-Weekly Drinker
8.972200E-01
Daily Drinker-vs-Occasional Drinker
2.441600E-01
Daily Drinker-vs-Social Drinker
9.210000E-01
Weekly Drinker-vs-Occasional Drinker
3.057600E-01
Weekly Drinker-vs-Social Drinker
9.661800E-01
Occasional Drinker-vs-Social Drinker
2.633200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.259600E-01
Normal-vs-Grade 2
7.790000E-01
Normal-vs-Grade 3
8.002200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.153640E-01
Grade 1-vs-Grade 3
2.027400E-01
Grade 1-vs-Grade 4
8.259600E-01
Grade 2-vs-Grade 3
5.516400E-01
Grade 2-vs-Grade 4
7.790000E-01
Grade 3-vs-Grade 4
8.002200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.145000E-01
Normal-vs-NonDiabetic
7.255000E-01
Diabetic-vs-NonDiabetic
4.864000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.347400E-01
Normal-vs-NoPancreatitis
6.281800E-01
Pancreatitis-vs-NoPancreatitis
6.188000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.237000E-01
Normal-vs-N1
3.816800E-01
N0-vs-N1
2.169000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.989200E-01
Normal-vs-TP53-NonMutant
7.423200E-01
TP53-Mutant-vs-TP53-NonMutant
7.341200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
